Innoviva (NASDAQ: INVA) reported Q2 EPS of $0.05, which may not compare to the analyst estimate of $0.44. Revenue for the quarter came in at $111.7 million versus the consensus estimate of $88.4 million.

For earnings history and earnings-related data on Innoviva (INVA) click here.